Our hypothesis is that a set of inflammatory mediators present in the blood of dengue patients with different clinical outcomes can differentially regulate the expression of adhesion molecules CD31, CD54, and CD106 and the CD147 molecule, in addition to altering the permeability of ECs in in vitro assays. Here, VCAM1 is linked to dengue disease.